Sign inJoin waitlistJoin the waitlist

Back to University Hospitals Cleveland Medical Center Dermatology

Favour Akinjiyan

Resident · Case Western Reserve University/University Hospitals Cleveland Medical Center

Credentials: · ·

History

Obstetrics and Gynecology
Washington University/B-JH/SLCH Consortium
2026–Present
Dermatology
Case Western Reserve University/University Hospitals Cleveland Medical Center
2025–Present
Resident
Case Western Reserve University/University Hospitals Cleveland Medical Center
Present
Missouri Baptist Medical Center
2025–2026
Washington University School of Medicine
2021–2025
UCSF
2023
New York Institute of Technology, NY
2013–2017

Research

CPSF3-dependent pre-mRNA processing as a druggable node in AML and Ewing's sarcoma
Nature Chemical Biology · 2020 · 73 citations
DDR2-regulated arginase activity in ovarian cancer-associated fibroblasts promotes collagen production and tumor progression
Oncogene · 2024 · First of 7 authors · 46 citations
DDR2 Expression in Cancer-Associated Fibroblasts Promotes Ovarian Cancer Tumor Invasion and Metastasis through Periostin-ITGB1
Cancers · 2022 · First of 5 authors · 27 citations

AZ
Alice Zhou
2 papers
GA
George Ansstas
2 papers
GL
Gregory Longmore
2 papers
Jordan Phillipps
2 papers · 1 as a resident
Katherine Fuh
2 papers
Soo Park
2 papers
AV
Ari Vanderwalde
1 paper
EA
Emily Alpert
1 paper
FA
Farah Abdulla
1 paper
GP
Gary Patti
1 paper
KK
Kevin Kim
1 paper
Omar Butt
1 paper · 1 as a fellow

Grants

The Action of DDR2 in Cancer-Associated Fibroblasts Promotes Ovarian Cancer Metastasis Through Increased Arginase-1 Activity.
National Cancer Institute · F30
Contact PI · $92.9K · Washington University
2023–2027